Director Timothy “Tim” J. Shea, Jr. was quoted in the article “Panel: Should Biologics Manufacturers Have to Disclose More About Their Patents?,” published by The Center for Biosimilars. This article summarizes a panel at the 2021 Festival of Biologics USA conference about the biosimilars pathway in the Biologics Price Competition and Innovation Act (BPCIA).
Related Professionals
Related Industries
Related Services
![Panel: Should Biologics Manufacturers Have to Disclose More About Their Patents?](https://www.sternekessler.com/app/themes/sternekessler/dist/images/0.gif)
Stay in the Know
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates![](https://www.sternekessler.com/app/uploads/2023/05/subscribe-cta.png)